Compare Cadila Healthcare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs AAYUSH FOOD & HERBS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE AAYUSH FOOD & HERBS CADILA HEALTHCARE/
AAYUSH FOOD & HERBS
 
P/E (TTM) x 25.2 -14.1 - View Chart
P/BV x 4.4 1.5 290.7% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 CADILA HEALTHCARE   AAYUSH FOOD & HERBS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-21
AAYUSH FOOD & HERBS
Mar-20
CADILA HEALTHCARE/
AAYUSH FOOD & HERBS
5-Yr Chart
Click to enlarge
High Rs50935 1,463.6%   
Low Rs25914 1,821.1%   
Sales per share (Unadj.) Rs147.5391.9 37.6%  
Earnings per share (Unadj.) Rs20.91.9 1,089.3%  
Cash flow per share (Unadj.) Rs28.02.2 1,262.1%  
Dividends per share (Unadj.) Rs3.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs126.919.6 646.5%  
Shares outstanding (eoy) m1,023.743.25 31,499.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.60.1 4,170.5%   
Avg P/E ratio x18.412.8 144.0%  
P/CF ratio (eoy) x13.711.0 124.3%  
Price / Book Value ratio x3.01.2 242.8%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m393,09280 494,439.3%   
No. of employees `000NANA-   
Total wages/salary Rs m22,5486 360,191.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m151,0221,274 11,855.7%  
Other income Rs m4491 44,455.4%   
Total revenues Rs m151,4711,275 11,881.6%   
Gross profit Rs m31,33518 171,042.6%  
Depreciation Rs m7,2481 747,216.5%   
Interest Rs m1,68810 17,050.5%   
Profit before tax Rs m22,8488 270,070.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4722 66,009.0%   
Profit after tax Rs m21,3766 343,114.0%  
Gross profit margin %20.71.4 1,443.0%  
Effective tax rate %6.426.4 24.4%   
Net profit margin %14.20.5 2,895.2%  
BALANCE SHEET DATA
Current assets Rs m87,160455 19,160.7%   
Current liabilities Rs m78,613285 27,537.1%   
Net working cap to sales %5.713.3 42.6%  
Current ratio x1.11.6 69.6%  
Inventory Days Days331 5,976.7%  
Debtors Days Days7610 791.9%  
Net fixed assets Rs m140,94310 1,478,940.2%   
Share capital Rs m1,02432 3,155.6%   
"Free" reserves Rs m128,89931 411,161.1%   
Net worth Rs m129,92364 203,641.1%   
Long term debt Rs m6,095115 5,289.4%   
Total assets Rs m228,103464 49,115.7%  
Interest coverage x14.51.9 783.8%   
Debt to equity ratio x01.8 2.6%  
Sales to assets ratio x0.72.7 24.1%   
Return on assets %10.13.5 291.1%  
Return on equity %16.59.8 168.6%  
Return on capital %18.010.3 175.9%  
Exports to sales %00-   
Imports to sales %10.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,911NA-   
Fx inflow Rs m63,5350-   
Fx outflow Rs m15,9110-   
Net fx Rs m47,6240-   
CASH FLOW
From Operations Rs m32,930-99 -33,145.4%  
From Investments Rs m-7,225-2 344,047.6%  
From Financial Activity Rs m-25,489107 -23,846.0%  
Net Cashflow Rs m-9055 -16,636.0%  

Share Holding

Indian Promoters % 74.8 51.3 145.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.8 0.0 -  
FIIs % 8.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.2 48.7 51.7%  
Shareholders   97,956 2,226 4,400.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DISHMAN PHARMA  BAL PHARMA  VENUS REMEDIES  GLENMARK LIFE SCIENCES  BIOCON   



Today's Market

Sensex Jumps 400 Points to Hit Fresh Record High; Bajaj Finance & ITC Top Gainers(09:30 am)

Asian stock markets are trading on a steady note today as traders weighed risks from China to the global recovery and the prospect of reduced Federal Reserve stimulus.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of CADILA HEALTHCARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit(Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Sep 17, 2021 10:07 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS